American Oncology Network Stock Price, News & Analysis

American Oncology Network (NASDAQ:AONC) and The Center for Cancer and Blood Disorders (CCBD) have announced the addition of two board-certified medical oncologists to their physician team. Dr. Garrett Diltz and Dr. Shreya Desai will serve patients in Bethesda and Germantown, Maryland.

Dr. Diltz, a graduate of The Ohio State University College of Medicine, completed his fellowship at MedStar Georgetown University Hospital. Dr. Desai, fluent in Gujarati and Hindi, completed her fellowship at the Medical College of Georgia. Both physicians will join CCBD's comprehensive cancer care services, which include diagnostics, treatments, clinical trials, and survivorship programs.

American Oncology Network (NASDAQ:AONC) announced that Genesis Cancer and Blood Institute, its partner practice, has welcomed Dr. Tyler Fugere to its physician care team. Dr. Fugere, a Board-certified medical oncologist and hematologist, joins a team of experienced physicians at Genesis, which operates 11 locations across Arkansas.

Dr. Fugere earned her medical degree, completed her internal medicine residency, and hematology-oncology fellowship at the University of Arkansas for Medical Sciences. She began seeing patients at Genesis's Benton and Little Rock clinics on August 1, 2025. Genesis Cancer and Blood Institute offers comprehensive services including cancer diagnosis, treatment, clinical trials, survivorship, and patient support services.

American Oncology Network (NASDAQ:AONC) has expanded its presence in Arkansas by welcoming Conway Hematology Oncology (CHO) to its network of community-based oncology practices. Founded in 1998 by Dr. Sue Tsuda, CHO has been providing hematology and oncology care in Conway for over 25 years.

The partnership will enable CHO to expand patient services, increase clinical trial offerings, and explore new market opportunities while maintaining their commitment to high-quality care. The practice features comprehensive oncology services, including advanced diagnostic and treatment technologies, an onsite laboratory, and private infusion suites.

The medical team includes Dr. Tsuda, a Board-certified medical oncologist and hematologist, along with two experienced Board-certified nurse practitioners, Christine Lightfoot and Courtney Nash.

American Oncology Network (AONC) has received reaccreditation from the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida, following an on-site inspection. The laboratory serves community oncology practices nationwide, processing thousands of patient samples.

The reaccreditation validates AON's commitment to maintaining high-quality standards in laboratory medicine, which is crucial for modern cancer care. The inspection process evaluated various aspects including records, quality control procedures, staff qualifications, equipment facilities, safety practices, and management systems.

American Oncology Network (NYSE:AONC) has expanded its Bispecific T-cell Engager (BiTE) therapy availability to more than 40 partner practice clinics across 18 states and Washington, D.C. This innovative immunotherapy treatment, implemented since March 2025, targets multiple cancer types including acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and extensive-stage small cell lung cancer.

The BiTE therapy works by engineering antibodies to target both cancer cell markers and T cell receptors, effectively bridging them together to enhance immune response against cancer cells. This expansion allows patients to receive advanced cancer treatment in community settings without traveling to major research institutions.

American Oncology Network (NASDAQ:AONC) has announced that Auerbach Hematology and Oncology Associates PC in Baltimore has joined its network and will be rebranded as The Center for Cancer and Blood Disorders (CCBD)—Baltimore. The practice, led by renowned experts Dr. Michael Auerbach and Dr. Huzefa Bahrain, along with CRNP Stephanie Horrocks, brings 24 years of experience in hematology and oncology care.

The partnership will enable the practice to expand patient services, increase clinical trial offerings, and explore new market opportunities while maintaining their commitment to high-quality, community-based care. CCBD-Baltimore will serve patients across Baltimore, Bethesda, and Germantown, Maryland, offering comprehensive cancer care services including diagnostics, treatment, clinical trials, and survivorship programs.

Florida Oncology and Hematology, a partner practice of American Oncology Network (NYSE:AONC), has expanded its Fort Myers clinic with the addition of radiology services. The enhanced facility now features PET services, 12 exam rooms, nearly 30 infusion chairs, and an on-site lab.

The practice, led by medical oncologists Dr. Van den Bergh, Dr. Parsa, and Dr. Mann, operates five clinics across Florida. The expansion includes advanced diagnostic capabilities and Radioligand Therapy for treating various cancers. The facility aims to provide comprehensive cancer care services in a single location for Lee County residents.

Hope Cancer Care of Nevada, in partnership with American Oncology Network (NYSE:AONC), has expanded its presence in Nevada with the opening of a new clinic in Henderson, marking its third location in the state. The new facility, located at 3035 W. Horizon Ridge Parkway, is led by board-certified medical oncologist Dr. Raja S. Mehdi.

The clinic features private exam rooms, an infusion room, and a specialty pharmacy for oral oncolytics. This expansion aims to provide Clark County residents with improved access to comprehensive oncology and hematology services, offering services including diagnosis, treatment, survivorship, and patient support close to home.

Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Health Parkway clinic in Naples to a larger facility at 15455 Collier Blvd., Suite 101 in the Lintree Medical Plaza. The expanded clinic features enhanced services including PET services, an infusion room, additional private exam rooms, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

Board-certified medical oncologist Dr. Ferdy Santiago and Board-certified hematologist Dr. Deborah Glick are now seeing patients at the new location. The practice also recently expanded its other Naples-area clinic at Goodlette-Frank Road in June. Florida Oncology and Hematology operates five clinic locations serving patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas.